EcoDrugPlus

Diacylglycerol O-Acyltransferase 1b

Ensembl ID : ENSATEG00000002316
Gene Symbol: DGAT1B
3 Cross references
187 Possible Orthologues:

Dihydroorotate Dehydrogenase

Ensembl ID : ENSATEG00000011177
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase B

Ensembl ID : ENSATEG00000002731
Gene Symbol: DPYDB
2 Cross references
217 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2a

Ensembl ID : ENSATEG00000023653
Gene Symbol: DDR2A
2 Cross references
205 Possible Orthologues:

Discoidin Domain-Containing Receptor 2-Like

Ensembl ID : ENSATEG00000021357
Gene Symbol: LOC113171405
2 Cross references
189 Possible Orthologues:

Dopamine Receptor D1a

Ensembl ID : ENSATEG00000001870
Gene Symbol: DRD1A
2 Cross references
188 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSATEG00000010207
Gene Symbol: DRD1B
3 Cross references
200 Possible Orthologues:

Dopamine Receptor D2a

Ensembl ID : ENSATEG00000011450
Gene Symbol: DRD2A
3 Cross references
207 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSATEG00000009656
Gene Symbol: DRD3
1 Cross references
203 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSATEG00000014683
Gene Symbol: EGLN1
3 Cross references
216 Possible Orthologues:

Egl-9 Family Hypoxia-Inducible Factor 2

Ensembl ID : ENSATEG00000012670
Gene Symbol: EGLN2
2 Cross references
195 Possible Orthologues:

Egl-9 Family Hypoxia-Inducible Factor 3

Ensembl ID : ENSATEG00000016315
Gene Symbol: EGLN3
1 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).